BioRestorative Therapies (BRTX) Receivables - Net (2016 - 2025)
BioRestorative Therapies (BRTX) has disclosed Receivables - Net for 11 consecutive years, with $13400.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Receivables - Net fell 91.88% year-over-year to $13400.0, compared with a TTM value of $13400.0 through Sep 2025, down 91.88%, and an annual FY2024 reading of $188400.0, up 876.17% over the prior year.
- Receivables - Net was $13400.0 for Q3 2025 at BioRestorative Therapies, down from $15000.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $188400.0 in Q4 2024 and bottomed at $5000.0 in Q4 2021.
- Average Receivables - Net over 5 years is $37252.6, with a median of $18000.0 recorded in 2021.
- The sharpest move saw Receivables - Net skyrocketed 876.17% in 2024, then plummeted 91.88% in 2025.
- Year by year, Receivables - Net stood at $5000.0 in 2021, then soared by 220.0% to $16000.0 in 2022, then rose by 20.62% to $19300.0 in 2023, then surged by 876.17% to $188400.0 in 2024, then plummeted by 92.89% to $13400.0 in 2025.
- Business Quant data shows Receivables - Net for BRTX at $13400.0 in Q3 2025, $15000.0 in Q2 2025, and $25000.0 in Q1 2025.